# A nurse is reviewing immunization schedules with the parents of a 2-year-old child. The child received the first dose of measles, mumps, and rubella (MMR) vaccine at 12 months of age. The parents are concerned about vaccine safety and ask about the timing of the second MMR dose. What is the most appropriate response by the nurse?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=541766  
> language: ko  
> subject: Adult Health

## 문제

A nurse is reviewing immunization schedules with the parents of a 2-year-old child. The child received the first dose of measles, mumps, and rubella (MMR) vaccine at 12 months of age. The parents are concerned about vaccine safety and ask about the timing of the second MMR dose. What is the most appropriate response by the nurse?

## 보기

1. The second MMR dose should be given at 18 months of age to ensure adequate protection before starting preschool.
2. The second MMR dose can be given anytime after 15 months, as long as there is at least a 1-month interval from the first dose.
3. The second MMR dose should be administered between 4-6 years of age, typically before school entry. **✔ 정답**
4. The second MMR dose is only necessary if the child will be traveling internationally or attending daycare in an outbreak area.

**정답: 3**

## 해설

CDC recommends the second MMR dose at 4-6 years for optimal long-term protection. Other options do not align with standard immunization schedules.

## 심화 해설

Understanding the MMR Vaccine Schedule

The question addresses the timing of the second dose of the measles, mumps, and rubella (MMR) vaccine, a critical component of routine childhood immunization. The first dose is typically administered at 12 to 15 months of age. The standard recommendation from the Advisory Committee on Immunization Practices (ACIP) is that the second dose be given between 4 and 6 years of age, which aligns with the pre-kindergarten entry requirement in most U.S. states. This timing is not arbitrary; it is designed to provide long-term protection by seroconverting the small percentage of children (approximately 2-5%) who do not develop adequate immunity after the first dose alone.

Why Option 3 is the Correct Answer

The most appropriate response is to inform the parents that the second dose is routinely scheduled between 4-6 years of age. This recommendation is based on the goal of ensuring high levels of population immunity before children enter a school setting, where the risk of exposure to infectious diseases increases. The recent resurgence of measles underscores the importance of this timing. A cohort study published in JAMA Network Open highlights that 1723 measles cases were reported in the U.S. as of November 2025, the highest level since elimination was declared in 2000 [1]. This outbreak context is directly linked to decreased MMR vaccination coverage and factors associated with delayed or missed vaccination by 2 years of age [1]. Adhering to the 4-6 year schedule is a key public health strategy to close immunity gaps and prevent outbreaks in congregate settings like schools.

Analysis of Incorrect Options

Option 1 is incorrect because 18 months is not the standard recommended age for the routine second dose. While the minimum interval between MMR doses is 4 weeks (28 days), giving the second dose at 18 months is an accelerated schedule, not the routine one. It may be considered in specific circumstances, such as during an outbreak or for international travel, but it is not the standard answer for a parent asking about routine timing.

Option 2 is misleading. Although technically true that the second dose can be given anytime after 15 months with at least a 4-week interval, this describes the minimum acceptable window, not the recommended standard schedule. Providing this as the primary answer without the context of the routine 4-6 year recommendation could lead to premature administration and confusion about school entry requirements.

Option 4 is factually incorrect. The second dose is a universal recommendation for all children to ensure individual and community immunity, not a conditional one reserved only for high-risk situations like international travel or outbreak areas. The study's finding of increased measles cases due to declining coverage reinforces that universal, on-time vaccination is essential, not situational [1].

Pathophysiology and Clinical Reasoning

The two-dose MMR schedule exists because of the immunology of live attenuated vaccines. The first dose induces a primary immune response, producing protective antibody levels in about 95% of recipients. The second dose acts as a "booster" to stimulate a secondary, anamnestic response in the 5% who failed to seroconvert initially, providing them with protection and solidifying long-term immunity in all recipients. From a public health perspective, achieving over 95% coverage with two doses is necessary to maintain herd immunity and prevent the re-establishment of endemic measles transmission, a goal that has been threatened by vaccination delays as documented in the recent literature [1].References (research sources)

- [1]Delayed or Absent First Dose of Measles, Mumps, and Rubella Vaccination.Research articleMasters NB, Goodwin Cartwright BM, Rodriguez PJ, Farrar KG, Do D, Stucky NL. (2026) · DOI: 10.1001/jamanetworkopen.2025.51814

## 임상 시나리오

Clinical Practice Guide: MMR Vaccine Second Dose Timing

This guide clarifies the standard recommendation for the second dose of the MMR vaccine, a common point of confusion for parents and a critical check-point in pediatric well-child visits.

Standard ACIP Recommendation

The second dose of MMR is routinely administered between **4 and 6 years of age**. This timing is strategically placed before school entry to ensure immunity and prevent outbreaks in school settings. The minimum interval between the first and second dose is 28 days, but the 4-6 year window is the standard of care.

Clinical Rationale

- **Primary Vaccine Failure:** Approximately 2-5% of children do not seroconvert after the first dose. The second dose provides a second chance for immunity.

- **School Entry Requirement:** All 50 U.S. states mandate two doses of MMR for kindergarten entry, making the 4-6 year visit the optimal time for administration.

- **Outbreak Response:** In the context of a measles outbreak, an early second dose (as early as 28 days after the first) may be recommended by local health authorities. However, this is an exception to the routine schedule.

Addressing Vaccine Hesitancy

When parents express concerns, emphasize that the two-dose series is over 97% effective at preventing measles. Reassure them that the timing is designed for their child's long-term health and community protection. Acknowledge their concerns and provide clear, evidence-based information without being dismissive.

Key Counseling Points for the 2-Year Visit

- Confirm the first MMR dose was given at 12-15 months.

- Educate parents that the next MMR dose is not due until the 4-6 year pre-kindergarten check-up.

- Use this opportunity to reinforce the safety and efficacy of the vaccine, especially given recent measles outbreaks.

- Document the plan clearly in the medical record to ensure follow-through.

## 핵심 개념

- **MMR Vaccine** — This is a combination of three live attenuated vaccines that prevent measles, mumps, and rubella.
- **ACIP (Advisory Committee on Immunization Practices)** — This is the expert committee that develops the vaccination recommendations of the U.S. CDC. It serves as the basis for all immunization schedules.
- **Vaccination Schedule** — This table systematically presents the types and timing of recommended vaccinations by age. It is designed for optimal immune effectiveness and public health.
- **Herd Immunity (집단면역)** — A phenomenon where, if a sufficient proportion of the population becomes immune through vaccination or other means, even individuals without immunity are indirectly protected from the disease.
- **Contraindication (접종 금기)** — Conditions under which vaccination should not be performed (e.g., history of severe allergic reaction (anaphylaxis) to any component of the vaccine, severe immunocompromised state, etc.).

## 같은 주제 문제

- [A nurse is preparing to administer the influenza vaccine to a 70-year-old client with chro…](https://mymerci.kr/pages/nclex_q.php?qn_id=540814)
- [A nurse is preparing to administer the influenza vaccine to a 65-year-old client. Which as…](https://mymerci.kr/pages/nclex_q.php?qn_id=540815)
- [A nurse is preparing to administer the seasonal influenza vaccine to a 45-year-old client.…](https://mymerci.kr/pages/nclex_q.php?qn_id=540816)
- [A 65-year-old client with a history of chronic obstructive pulmonary disease (COPD) is sch…](https://mymerci.kr/pages/nclex_q.php?qn_id=540817)
- [A nurse is reviewing immunization schedules with parents of a 15-month-old child. The pare…](https://mymerci.kr/pages/nclex_q.php?qn_id=541767)
- [A 12-month-old toddler is brought to the pediatric clinic for routine immunizations. The m…](https://mymerci.kr/pages/nclex_q.php?qn_id=541768)
- [A nurse is reviewing immunization schedules with parents of a 15-month-old child. Which st…](https://mymerci.kr/pages/nclex_q.php?qn_id=541769)
- [A 4-year-old child is brought to the pediatric clinic for routine immunizations. The child…](https://mymerci.kr/pages/nclex_q.php?qn_id=542318)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._